FKBP10
protein-codingFKBP prolyl isomerase 10, the group of EF-hand domain containing|FKBP prolyl isomerases
Gene summary
The protein encoded by this gene belongs to the FKBP-type peptidyl-prolyl cis/trans isomerase (PPIase) family. This protein localizes to the endoplasmic reticulum and acts as a molecular chaperone. Alternatively spliced variants encoding different isoforms have been reported, but their biological validity has not been determined.[provided by RefSeq, Nov 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0009804
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0017195
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0008148
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0019019
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012592
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0009806
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0015241
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012592
Submitter: Illumina
The FKBP10 gene is located on chromosome 17 at 17q21.2 and encodes the FKBP prolyl isomerase 10 protein, which is a member of the immunophilins group of proteins. FKBP prolyl isomerase 10 protein has peptidyl prolyl cis-trans isomerase activity (PPIase) that accelerates protein folding, and it may also enable collagen folding by acting as a collagen chaperon. FKBP10 was first reported in relation to autosomal recessive osteogenesis imperfecta with or without joint contractures in 2010 (20362275: Alanay et al. (2010). At least six unique loss-of-function variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least six probands from four publications (20362275: Alanay et al. 2010; 21567934: Shaheen et al. 2011; 20839288: Kelley et al. 2011; 27762305: Xu et al. 2017). Segregation was noted in four families but with insufficient evidence to score. More genetic evidence is available in the literature, but the maximum score for genetic evidence has been reached. This gene-disease relationship is supported by expression studies and animal models. In summary, FKBP10 is definitively associated with autosomal recessive osteogenesis imperfecta with or without joint contractures. Lumping and Splitting: Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found no difference in molecular mechanism(s) underlying the disease entities (Marini et al. 2014): Bruck syndrome 1 (MIM:259450) and Osteogenesis imperfecta, type XI (MIM:610968).
Inheritance Pattern: AR
Disease ID:MONDO:0012592
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009806
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Dental; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Bisphosphonates may reduce fracture frequency, but it is unclear if early (genomic) diagnosis would be additionally beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to FKBP10 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_021939.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 203 | 3 | 209 | ||
| missense | 10 | 195 | 11 | 216 | ||
| nonsense | 8 | 3 | 11 | |||
| start loss | 1 | 1 | 2 | |||
| frameshift | 29 | 16 | 45 | |||
| splice donor/acceptor (+/-2bp) | 3 | 10 | 1 | 14 | ||
| Total | 41 | 40 | 199 | 214 | 3 | 497 |
Highest pathogenic variant AF is 0.00009669921
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_068758.3 | 10 | MANE Select | |
| Ensembl | ENSP00000317232.4 | 10 | MANE Select | |
| Ensembl | ENSP00000408232.1 | 3 | Standard | |
| Ensembl | ENSP00000416822.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein peptidyl-prolyl isomerization
Molecular Function
- peptidyl-prolyl cis-trans isomerase activity
- calcium ion binding
- FK506 binding
Cellular Component
- endoplasmic reticulum lumen
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000321562
- Coding exons
- 10
- Length
- 10534
- Individuals with no LoFs
- 125670
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 78
- Defined
- 125748
- p
- 0.000310
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.713 | 322 | 360 | 0.894 | 0.0000239 | 3769 |
| Missense (PolyPhen) | 128 | 158.51 | 0.80752 | 1677 | ||
| Synonymous | -1.04 | 177 | 160 | 1.10 | 0.0000115 | 1207 |
| Loss of Function | 2.13 | 13 | 24.3 | 0.535 | 0.00000139 | 259 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00068 | 0.00068 | rare |
| Latino/Admixed American | 0.00023 | 0.00023 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0.00037 | 0.00037 | rare |
| European (Non-Finnish) | 0.00033 | 0.00032 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: PPIases accelerate the folding of proteins during protein synthesis.;
- Disease
- DISEASE: Osteogenesis imperfecta 11 (OI11) [MIM:610968]: A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form. {ECO:0000269|PubMed:20362275, ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Bruck syndrome 1 (BRKS1) [MIM:259450]: A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. {ECO:0000269|PubMed:20839288, ECO:0000269|PubMed:22949511}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- LoFtool
- 0.337
- RVIS EVS
- -0.75
- RVIS percentile EVS
- 13.71
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.722
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |